This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Southwest Airlines defends US antitrust claims against generic drug companies

( February 11, 2026, 23:31 GMT | Official Statement) -- MLex Summary: Southwest Airlines opposed motions to dismiss US antitrust claims against Aurobindo Pharma, Sandoz, Actavis, and other generic drug companies, saying they fail to satisfy their burden of proof. “At a minimum, a party seeking to dismiss needs to explain why the plaintiff’s allegations are insufficient for the claim to survive. Defendants make no attempt to do that,” Southwest argued.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections